Perspective Therapeutics (CATX) Other Working Capital Changes (2024 - 2026)
Perspective Therapeutics (CATX) reported Other Working Capital Changes of $51000.0 for Q1 2026, down 43.33% on a YoY basis from $90000.0 in Q1 2025, and up 15.91% sequentially from $44000.0 in Q4 2025.
Perspective Therapeutics (CATX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 3 years of Other Working Capital Changes data on file, last reported at $51000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 43.33% year-over-year to $51000.0; the trailing twelve-month figure through Mar 2026 stood at $292000.0 (up 101.38% YoY), and the FY2025 full-year result was $331000.0, up 501.82% from the prior year.
- Other Working Capital Changes grew to $51000.0 in Q1 2026, from $44000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $27.8 million in Q2 2024 to a low of -$1.2 million in Q2 2025.
- A 5-year average of $1.8 million and a median of $60000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes decreased 20.0% in 2025 and plunged 43.33% in 2026, its largest moves.
- Tracing CATX's Other Working Capital Changes over 3 years: stood at $55000.0 in 2024, then fell by 20.0% to $44000.0 in 2025, then gained by 15.91% to $51000.0 in 2026.
- Business Quant data shows CATX's Other Working Capital Changes at $51000.0 in Q1 2026, $44000.0 in Q4 2025, and $58000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |